Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383:2652–64.

Article  CAS  PubMed  Google Scholar 

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1–106.

Article  PubMed  Google Scholar 

Cosnes J, Gower–Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–94.e4.

Article  PubMed  Google Scholar 

Ashton JJ, Peiris D, Green Z, Johnson MJ, Marino LV, Griffiths M, et al. Routine abdominal magnetic resonance imaging can determine psoas muscle area in paediatric Crohn’s disease and correlates with bioelectrical impedance spectroscopy measures of lean mass. Clin Nutr ESPEN. 2021;42:233–8.

Article  PubMed  Google Scholar 

Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18:509–23.

Article  PubMed  Google Scholar 

Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol. 2017;2:e17.

Article  Google Scholar 

Rennie K, Jebb S. Prevalence of obesity in Great Britain. Obes Rev. 2005;6:11–2.

Article  CAS  PubMed  Google Scholar 

Conolly A, Neave A. Health Survey for England 2015 Children’s body mass index, overweight and obesity. London: Health and Social Care Information Centre. 2016.

WHO. Obesity and overweight 2021 [Available from: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.

Khakoo NS, Ioannou S, Khakoo NS, Vedantam S, Pearlman M. Impact of obesity on inflammatory bowel disease. Curr Gastroenterol Rep. 2022;24:1–11.

Article  Google Scholar 

Johnson AM, Loftus EV. Impact of obesity on the management of inflammatory bowel disease. Gastroenterol Hepatol. 2020;16:350.

Google Scholar 

Long MD, Crandall WV, Leibowitz IH, Duffy L, Del Rosario F, Kim SC, et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis. 2010;17:2162–8.

Article  PubMed  Google Scholar 

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.

Article  ADS  CAS  PubMed  Google Scholar 

Shoelson S, Lee J, Goldfine A. Inflammation and insulin resistance. J Clin Investig. 2006;116:1793–801.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mendall M, Patel P, Ballam L, Strachan D, Northfield T. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Bmj. 1996;312:1061–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomark Prev. 2004;13:279–84.

Article  CAS  Google Scholar 

Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation. 2004;109:3022–8.

Article  CAS  PubMed  Google Scholar 

Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Investig. 1995;95:2409–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2276–83.

Article  CAS  PubMed  Google Scholar 

Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429–33.

Article  CAS  PubMed  Google Scholar 

Siegmund B. Mesenteric fat in Crohn’s disease: the hot spot of inflammation? Gut. 2012;61:3–5.

Article  CAS  PubMed  Google Scholar 

Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre J, Cosnes J. Crohn’s disease clinical course and severity in obese patients. Clin Nutr. 2002;21:51–7.

Article  CAS  PubMed  Google Scholar 

Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR. The impact of increased body mass index on the clinical course of Crohn’s disease. Clin Gastroenterol Hepatol. 2006;4:482–8.

Article  PubMed  Google Scholar 

Causey MW, Johnson EK, Miller S, Martin M, Maykel J, Steele SR. The impact of obesity on outcomes following major surgery for Crohn’s disease: an American College of Surgeons National Surgical Quality Improvement Program assessment. Dis Colon Rectum. 2011;54:1488–95.

Article  PubMed  Google Scholar 

Nic Suibhne T, Raftery TC, McMahon O, Walsh C, O’Morain C, O’Sullivan M. High prevalence of overweight and obesity in adults with Crohn’s disease: associations with disease and lifestyle factors. J Crohn’s Colitis. 2013;7:e241–e8.

Article  Google Scholar 

Flores A, Burstein E, Cipher DJ, Feagins LA. Obesity in inflammatory bowel disease: a marker of less severe disease. Digestive Dis Sci. 2015;60:2436–45.

Article  CAS  Google Scholar 

Zwintscher NP, Horton JD, Steele SR. Obesity has minimal impact on clinical outcomes in children with inflammatory bowel disease. J Pediatr Surg. 2014;49:265–8.

Article  PubMed  Google Scholar 

Yerushalmy-Feler A, Ben-Tov A, Weintraub Y, Amir A, Galai T, Moran-Lev H, et al. High and low body mass index may predict severe disease course in children with inflammatory bowel disease. Scand J Gastroenterol. 2018;53:708–13.

Article  PubMed  Google Scholar 

Chandrakumar A, Wang A, Grover K, El-Matary W. Obesity is more common in children newly diagnosed with ulcerative colitis as compared to those with Crohn disease. J Pediatr Gastroenterol Nutr. 2019;70:593–7.

Article  Google Scholar 

Yerushalmy-Feler A, Galai T, Moran-Lev H, Ben-Tov A, Dali-Levy M, Weintraub Y, et al. BMI in the lower and upper quartiles at diagnosis and at 1-year follow-up is significantly associated with higher risk of disease exacerbation in pediatric inflammatory bowel disease. Eur J Pediatr. 2020;180:21–9.

Article  PubMed  Google Scholar 

Jain A, Bricker J, Kappelman MD, Dotson JL. Overweight and obese status is not associated with disease activity for children and adolescents with newly diagnosed inflammatory bowel disease. Am J Gastroenterol. 2022;117:1146–53.

Article  CAS  PubMed  Google Scholar 

Rodin I, Chan J, Meleady L, Hii C, Lawrence S, Jacobson K. High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease. JGH Open. 2019;4:446–53.

Article  PubMed  PubMed Central  Google Scholar 

Group WMGRS, de Onis M. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr. 2006;95:76–85.

Article  Google Scholar 

Parkes M. IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis. Gut. 2019;68:1537–40.

Article  CAS  PubMed  Google Scholar 

Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.

Article  PubMed  Google Scholar 

Von Graffenried T, Schoepfer AM, Rossel J-B, Greuter T, Safroneeva E, Godat S, et al. Impact of overweight and obesity on disease outcome in the pediatric swiss inflammatory bowel disease cohort. JPGN Rep. 2022;3:e193.

Article  Google Scholar 

Greuter T, Porchet F, Braga-Neto MB, Rossel J-B, Biedermann L, Schreiner P, et al. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: results from the Swiss inflammatory bowel disease cohort. U Eur Gastroenterol J. 2020;8:1196–207.

Article  CAS  Google Scholar 

Singla MB, Eickhoff C, Betteridge J. Extraintestinal manifestations are common in obese patients with Crohn’s disease. Inflamm Bowel Dis. 2017;23:1637–42.

Article  PubMed  Google Scholar 

Pringle PL, Stewart KO, Peloquin JM, Sturgeon HC, Nguyen D, Sauk J, et al. Body mass index, genetic susceptibility, and risk of complications among individuals with Crohn’s disease. Inflamm Bowel Dis. 2015;21:2304–10.

PubMed  Google Scholar 

Wardle RA, Thapaliya G, Nowak A, Radford S, Dalton M, Finlayson G, et al. An examination of appetite and disordered eating in active Crohn’s disease. J Crohn’s Colitis. 2018;12:819–25.

Article  Google Scholar 

Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V. et al.Population‐based assessment of adverse events associated with long‐term glucocorticoid use.Arthritis Care Res. 2006;55:420–6.

Article  Google Scholar 

Wung PK, Anderson T, Fontaine KR, Hoffman GS, Specks U, Merkel PA, et al. Effects of glucocorticoids on weight change during the treatment of Wegener’s granulomatosis. Arthritis Care Res. 2008;59:746–53.

Article